For years, P-glycoprotein (P-gp) has been purported to be a membrane transporter capable of selectively transporting many (but not all) lipophilic anticancer drugs with diverse chemical structures. Because the alleged functions of P-gp provide a straightforward, near-perfect explanation for the mole
OC144-093, a Novel P Glycoprotein Inhibitor for the Enhancement of Antiepileptic Therapy
โ Scribed by Michael J. Newman; Ross Dixon; Barry Toyonaga
- Publisher
- John Wiley and Sons
- Year
- 2003
- Weight
- 53 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A novel probe was developed to measure drug association with the F1\*S variant of the human serum protein alpha 1-acid glycoprotein (AGP). The molecule 2hydroxy-3,5-diiodo-N-[2(diethylamino)ethyl]benzamide (DEDIC) binds to AGP, quenching its native ยฏuorescence. This quenching was ยฎtted to a two-site
## Background: Rheumatoid arthritis is characterized by inflammation of the synovial tissue. high systemic doses are necessary to achieve therapeutic levels of anti-rheumatic drugs in the joints. gene transfer might provide a more efficient delivery system for genes encoding therapeutic proteins.